title: Which policy for new psychoactive drugs?
authors.affiliation: Research Institute for Public Health and Addiction, Zurich University, Konradstr. 32, Zurich CH-8031, Switzerland.
authors.forename: Ambros
authors.initials: A
authors.lastname: Uchtenhagen
mesh_terms: D013287:Illicit Drugs; D011619:Psychotropic Drugs
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs
keywords: Consumer protection; drug policy; drug specific effects; harms; health benefits; medication testing; monitoring; new psychoactive drugs; psychoactive drugs; risk assessment